{"pmid":32389723,"title":"Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.","text":["Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.","In the current episode of novel coronavirus (SARS-CoV-2) spreads, antiviral drug discovery is of great importance. Auto dock vina was used to screen potential drugs by molecular docking with the structure protein and non-structure protein sites of new coronavirus. Ribavirin, a common antiviral drug, as well as remdesivir, chloroquine and luteolin, were all studied. Honeysuckle is generally believed to have antiviral effect in traditional Chinese medicine, the main flavonoid in which is Luteolin. In the study, it was found luteolin could bind to the same sites of main protease of SARS-CoV-2 as the control molecular with a high affinity. Chloroquine, was proved clinically effective, can bind to the main protease, which may be the possible antiviral mechanism. And the study was restricted to molecular docking without validation by MD simulations. Interactions with the main protease may play a key role in in fighting against viruses. Luteolin is a potential antiviral molecule worthy of attention.","Int J Antimicrob Agents","Yu, Ran","Chen, Liang","Lan, Rong","Shen, Rong","Li, Peng","32389723"],"abstract":["In the current episode of novel coronavirus (SARS-CoV-2) spreads, antiviral drug discovery is of great importance. Auto dock vina was used to screen potential drugs by molecular docking with the structure protein and non-structure protein sites of new coronavirus. Ribavirin, a common antiviral drug, as well as remdesivir, chloroquine and luteolin, were all studied. Honeysuckle is generally believed to have antiviral effect in traditional Chinese medicine, the main flavonoid in which is Luteolin. In the study, it was found luteolin could bind to the same sites of main protease of SARS-CoV-2 as the control molecular with a high affinity. Chloroquine, was proved clinically effective, can bind to the main protease, which may be the possible antiviral mechanism. And the study was restricted to molecular docking without validation by MD simulations. Interactions with the main protease may play a key role in in fighting against viruses. Luteolin is a potential antiviral molecule worthy of attention."],"journal":"Int J Antimicrob Agents","authors":["Yu, Ran","Chen, Liang","Lan, Rong","Shen, Rong","Li, Peng"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389723","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ijantimicag.2020.106012","keywords":["2019-ncov","autodock vina","chloroquine","luteolin","remdesivir","ribavirin"],"locations":["vina","Chinese","flavonoid"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Chloroquine","Luteolin","Flavonoids","Ribavirin","remdesivir"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666528580014702592,"score":9.490897,"similar":[{"pmid":32395606,"pmcid":"PMC7211761","title":"Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study.","text":["Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study.","The aim of this study was to develop an appropriate anti-viral drug against the SARS-CoV-2 virus. An immediately qualifying strategy would be to use existing powerful drugs from various virus treatments. The strategy in virtual screening of antiviral databases for possible therapeutic effect would be to identify promising drug molecules, as there is currently no vaccine or treatment approved against COVID-19. Targeting the main protease (pdb id: 6LU7) is gaining importance in anti-CoV drug design. In this conceptual context, an attempt has been made to suggest an in silico computational relationship between US-FDA approved drugs, plant-derived natural drugs, and Coronavirus main protease (6LU7) protein. The evaluation of results was made based on Glide (Schrodinger) dock score. Out of 62 screened compounds, the best docking scores with the targets were found for compounds: lopinavir, amodiaquine, and theaflavin digallate (TFDG). Molecular dynamic (MD) simulation study was also performed for 20 ns to confirm the stability behaviour of the main protease and inhibitor complexes. The MD simulation study validated the stability of three compounds in the protein binding pocket as potent binders.","Inform Med Unlocked","Peele, K Abraham","Chandrasai, P","Srihansa, T","Krupanidhi, S","Sai, A Vijaya","Babu, D John","Indira, M","Reddy, A Ranganadha","Venkateswarulu, T C","32395606"],"abstract":["The aim of this study was to develop an appropriate anti-viral drug against the SARS-CoV-2 virus. An immediately qualifying strategy would be to use existing powerful drugs from various virus treatments. The strategy in virtual screening of antiviral databases for possible therapeutic effect would be to identify promising drug molecules, as there is currently no vaccine or treatment approved against COVID-19. Targeting the main protease (pdb id: 6LU7) is gaining importance in anti-CoV drug design. In this conceptual context, an attempt has been made to suggest an in silico computational relationship between US-FDA approved drugs, plant-derived natural drugs, and Coronavirus main protease (6LU7) protein. The evaluation of results was made based on Glide (Schrodinger) dock score. Out of 62 screened compounds, the best docking scores with the targets were found for compounds: lopinavir, amodiaquine, and theaflavin digallate (TFDG). Molecular dynamic (MD) simulation study was also performed for 20 ns to confirm the stability behaviour of the main protease and inhibitor complexes. The MD simulation study validated the stability of three compounds in the protein binding pocket as potent binders."],"journal":"Inform Med Unlocked","authors":["Peele, K Abraham","Chandrasai, P","Srihansa, T","Krupanidhi, S","Sai, A Vijaya","Babu, D John","Indira, M","Reddy, A Ranganadha","Venkateswarulu, T C"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395606","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.imu.2020.100345","keywords":["anti-malarial drugs","antiviral compounds","coronavirus","simulations"],"e_drugs":["theaflavin digallate","Lopinavir"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666627828015169537,"score":362.06705},{"pmid":32340562,"title":"A Molecular Modeling Approach to Identify Effective Antiviral Phytochemicals against the Main Protease of SARS-CoV-2.","text":["A Molecular Modeling Approach to Identify Effective Antiviral Phytochemicals against the Main Protease of SARS-CoV-2.","The main protease of SARS-CoV-2 is one of the important targets to design and develop antiviral drugs. In this study, we have selected 40 antiviral phytochemicals to find out the best candidates which can act as potent inhibitors against the main protease. Molecular docking is performed using AutoDock Vina and GOLD suite to determine the binding affinities and interactions between the phytochemicals and the main protease. The selected candidates strongly interact with the key Cys145 and His41 residues. To validate the docking interactions, 100 ns molecular dynamics (MD) simulations on the five top-ranked inhibitors including hypericin, cyanidin 3-glucoside, baicalin, glabridin, and alpha-ketoamide-11r were performed. Principal component analysis (PCA) of potential energy components of MD discloses that baicalin, cyanidin 3-glucoside, and alpha-ketoamide-11r have structural similarity with the apo-form of the main protease. These findings are also strongly supported by root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), radius of gyration (Rg), and solvent accessible surface area (SASA) investigations. PCA is also used to find out the quantitative structure-activity relationship (QSAR) for pattern recognition of the best ligands. Multiple linear regression (MLR) of QSAR reveals the R(2) value of 0.842 for the training set and 0.753 for the test set. Our proposed MLR model can predict the favorable binding energy compared with the binding energy detected from molecular docking. ADMET analysis demonstrates that these candidates appear to be safer inhibitors. Our comprehensive computational and statistical analysis show that these selected phytochemicals can be used as potential inhibitors against the SARS-CoV-2.","J Biomol Struct Dyn","Islam, Rajib","Parves, Rimon","Paul, Archi Sundar","Uddin, Nizam","Rahman, Md Sajjadur","Mamun, Abdulla Al","Hossain, Md Nayeem","Ali, Md Ackas","Halim, Mohammad A","32340562"],"abstract":["The main protease of SARS-CoV-2 is one of the important targets to design and develop antiviral drugs. In this study, we have selected 40 antiviral phytochemicals to find out the best candidates which can act as potent inhibitors against the main protease. Molecular docking is performed using AutoDock Vina and GOLD suite to determine the binding affinities and interactions between the phytochemicals and the main protease. The selected candidates strongly interact with the key Cys145 and His41 residues. To validate the docking interactions, 100 ns molecular dynamics (MD) simulations on the five top-ranked inhibitors including hypericin, cyanidin 3-glucoside, baicalin, glabridin, and alpha-ketoamide-11r were performed. Principal component analysis (PCA) of potential energy components of MD discloses that baicalin, cyanidin 3-glucoside, and alpha-ketoamide-11r have structural similarity with the apo-form of the main protease. These findings are also strongly supported by root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), radius of gyration (Rg), and solvent accessible surface area (SASA) investigations. PCA is also used to find out the quantitative structure-activity relationship (QSAR) for pattern recognition of the best ligands. Multiple linear regression (MLR) of QSAR reveals the R(2) value of 0.842 for the training set and 0.753 for the test set. Our proposed MLR model can predict the favorable binding energy compared with the binding energy detected from molecular docking. ADMET analysis demonstrates that these candidates appear to be safer inhibitors. Our comprehensive computational and statistical analysis show that these selected phytochemicals can be used as potential inhibitors against the SARS-CoV-2."],"journal":"J Biomol Struct Dyn","authors":["Islam, Rajib","Parves, Rimon","Paul, Archi Sundar","Uddin, Nizam","Rahman, Md Sajjadur","Mamun, Abdulla Al","Hossain, Md Nayeem","Ali, Md Ackas","Halim, Mohammad A"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340562","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1080/07391102.2020.1761883","keywords":["antiviral phytochemicals","covid-19","sars-cov-2","molecular docking","molecular dynamics"],"locations":["hypericin","cyanidin","QSAR"],"e_drugs":["hypericin","glabridin","baicalin","cyanidin 3-O-glucoside"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138495136038914,"score":354.53287},{"pmid":32486229,"title":"Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations.","text":["Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations.","The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic that started in December 2019. The effective drug target among coronaviruses is the main protease M(pro), because of its essential role in processing the polyproteins that are translated from the viral RNA. In this study, the bioactivity of some selected heterocyclic drugs named Favipiravir (1), Amodiaquine (2), 2'-Fluoro-2'-deoxycytidine (3), and Ribavirin (4) was evaluated as inhibitors and nucleotide analogues for COVID-19 using computational modeling strategies. The density functional theory (DFT) calculations were performed to estimate the thermal parameters, dipole moment, polarizability, and molecular electrostatic potential of the present drugs; additionally, Mulliken atomic charges of the drugs as well as the chemical reactivity descriptors were investigated. The nominated drugs were docked on SARS-CoV-2 main protease (PDB: 6LU7) to evaluate the binding affinity of these drugs. Besides, the computations data of DFT the docking simulation studies was predicted that the Amodiaquine (2) has the least binding energy (-7.77 Kcal/mol) and might serve as a good inhibitor to SARS-CoV-2 comparable with the approved medicines, hydroxychloroquine, and remdesivir which have binding affinity -6.06 and -4.96 Kcal/mol, respectively. The high binding affinity of 2 was attributed to the presence of three hydrogen bonds along with different hydrophobic interactions between the drug and the critical amino acids residues of the receptor. Finally, the estimated molecular electrostatic potential results by DFT were used to illustrate the molecular docking findings. The DFT calculations showed that drug 2 has the highest of lying HOMO, electrophilicity index, basicity, and dipole moment. All these parameters could share with different extent to significantly affect the binding affinity of these drugs with the active protein sites.","Int J Mol Sci","Hagar, Mohamed","Ahmed, Hoda A","Aljohani, Ghadah","Alhaddad, Omaima A","32486229"],"abstract":["The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic that started in December 2019. The effective drug target among coronaviruses is the main protease M(pro), because of its essential role in processing the polyproteins that are translated from the viral RNA. In this study, the bioactivity of some selected heterocyclic drugs named Favipiravir (1), Amodiaquine (2), 2'-Fluoro-2'-deoxycytidine (3), and Ribavirin (4) was evaluated as inhibitors and nucleotide analogues for COVID-19 using computational modeling strategies. The density functional theory (DFT) calculations were performed to estimate the thermal parameters, dipole moment, polarizability, and molecular electrostatic potential of the present drugs; additionally, Mulliken atomic charges of the drugs as well as the chemical reactivity descriptors were investigated. The nominated drugs were docked on SARS-CoV-2 main protease (PDB: 6LU7) to evaluate the binding affinity of these drugs. Besides, the computations data of DFT the docking simulation studies was predicted that the Amodiaquine (2) has the least binding energy (-7.77 Kcal/mol) and might serve as a good inhibitor to SARS-CoV-2 comparable with the approved medicines, hydroxychloroquine, and remdesivir which have binding affinity -6.06 and -4.96 Kcal/mol, respectively. The high binding affinity of 2 was attributed to the presence of three hydrogen bonds along with different hydrophobic interactions between the drug and the critical amino acids residues of the receptor. Finally, the estimated molecular electrostatic potential results by DFT were used to illustrate the molecular docking findings. The DFT calculations showed that drug 2 has the highest of lying HOMO, electrophilicity index, basicity, and dipole moment. All these parameters could share with different extent to significantly affect the binding affinity of these drugs with the active protein sites."],"journal":"Int J Mol Sci","authors":["Hagar, Mohamed","Ahmed, Hoda A","Aljohani, Ghadah","Alhaddad, Omaima A"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32486229","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3390/ijms21113922","keywords":["covid 19","dft calculations","n-heterocycles","hydroxychloroquine","molecular docking"],"locations":["Amodiaquine"],"e_drugs":["2'-fluoro-2'-deoxycytidine","favipiravir","remdesivir","Amodiaquine","Hydroxychloroquine","Ribavirin"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668623433677668352,"score":343.5066},{"pmid":32362243,"title":"Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.","text":["Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.","The 2019-novel coronavirus (nCoV) has caused a global health crisis by causing coronavirus disease-19 (COVID-19) pandemic in the human population. The unavailability of specific vaccines and anti-viral drug for nCoV, science demands sincere efforts in the field of drug design and discovery for COVID-19. The novel coronavirus main protease (SARS-CoV-2 Mpro) play a crucial role during the disease propagation, and hence SARS-CoV-2 Mpro represents as a drug target for the drug discovery. Herein, we have applied bioinformatics approach for screening of chemical compounds from Indian spices as potent inhibitors of SARS-CoV-2 main protease (PDBID: 6Y84). The structure files of Indian spices chemical compounds were taken from PubChem database or Zinc database and screened by molecular docking, by using AutoDock-4.2, MGLTools-1.5.6, Raccoon virtual screening tools. Top 04 hits based on their highest binding affinity were analyzed. Carnosol exhibited highest binding affinity -8.2 Kcal/mol and strong and stable interactions with the amino acid residues present on the active site of SARS-CoV-2 Mpro. Arjunglucoside-I (-7.88 Kcal/mol) and Rosmanol (-7.99 Kcal/mol) also showed a strong and stable binding affinity with favourable ADME properties. These compounds on MD simulations for 50ns shows strong hydrogen-bonding interactions with the protein active site and remains stable inside the active site. Our virtual screening results suggest that these small chemical molecules can be used as potential inhibitors against SARS-CoV-2 Mpro and may have an anti-viral effect on nCoV. However, further validation and investigation of these inhibitors against SARS-CoV-2 main protease are needed to claim their candidacy for clinical trials.","J Biomol Struct Dyn","Umesh","Kundu, Debanjan","Selvaraj, Chandrabose","Singh, Sanjeev Kumar","Dubey, Vikash Kumar","32362243"],"abstract":["The 2019-novel coronavirus (nCoV) has caused a global health crisis by causing coronavirus disease-19 (COVID-19) pandemic in the human population. The unavailability of specific vaccines and anti-viral drug for nCoV, science demands sincere efforts in the field of drug design and discovery for COVID-19. The novel coronavirus main protease (SARS-CoV-2 Mpro) play a crucial role during the disease propagation, and hence SARS-CoV-2 Mpro represents as a drug target for the drug discovery. Herein, we have applied bioinformatics approach for screening of chemical compounds from Indian spices as potent inhibitors of SARS-CoV-2 main protease (PDBID: 6Y84). The structure files of Indian spices chemical compounds were taken from PubChem database or Zinc database and screened by molecular docking, by using AutoDock-4.2, MGLTools-1.5.6, Raccoon virtual screening tools. Top 04 hits based on their highest binding affinity were analyzed. Carnosol exhibited highest binding affinity -8.2 Kcal/mol and strong and stable interactions with the amino acid residues present on the active site of SARS-CoV-2 Mpro. Arjunglucoside-I (-7.88 Kcal/mol) and Rosmanol (-7.99 Kcal/mol) also showed a strong and stable binding affinity with favourable ADME properties. These compounds on MD simulations for 50ns shows strong hydrogen-bonding interactions with the protein active site and remains stable inside the active site. Our virtual screening results suggest that these small chemical molecules can be used as potential inhibitors against SARS-CoV-2 Mpro and may have an anti-viral effect on nCoV. However, further validation and investigation of these inhibitors against SARS-CoV-2 main protease are needed to claim their candidacy for clinical trials."],"journal":"J Biomol Struct Dyn","authors":["Umesh","Kundu, Debanjan","Selvaraj, Chandrabose","Singh, Sanjeev Kumar","Dubey, Vikash Kumar"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362243","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1080/07391102.2020.1763202","keywords":["adme","bioinformatics","corona virus disease-2019 (covid-19","molecular docking","novel coronavirus (ncov)","novel coronavirus main protease (sars-cov-2 mpro)"],"locations":["Indian","Indian","Raccoon","Indian"],"countries":["India"],"countries_codes":["IND|India"],"e_drugs":["sericoside","carnosol","rosmanol"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495987482624,"score":314.53387},{"pmid":32362245,"title":"An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.","text":["An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.","A new strain of a novel infectious disease affecting millions of people, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently been declared as a pandemic by the World Health Organization (WHO). Currently, several clinical trials are underway to identify specific drugs for the treatment of this novel virus. The inhibition of the SARS-CoV-2 main protease is necessary for the blockage of the viral replication. Here, in this study, we have utilized a blind molecular docking approach to identify the possible inhibitors of the SARS-CoV-2 main protease, by screening a total of 33 molecules which includes natural products, anti-virals, anti-fungals, anti-nematodes and anti-protozoals. All the studied molecules could bind to the active site of the SARS-CoV-2 protease (PDB: 6Y84), out of which rutin (a natural compound) has the highest inhibitor efficiency among the 33 molecules studied, followed by ritonavir (control drug), emetine (anti-protozoal), hesperidin (a natural compound), lopinavir (control drug) and indinavir (anti-viral drug). All the molecules, studied out here could bind near the crucial catalytic residues, HIS41 and CYS145 of the main protease, and the molecules were surrounded by other active site residues like MET49, GLY143, HIS163, HIS164, GLU166, PRO168, and GLN189. As this study is based on molecular docking, hence being particular about the results obtained, requires extensive wet-lab experimentation and clinical trials under in vitro as well as in vivo conditions.","J Biomol Struct Dyn","Das, Sourav","Sarmah, Sharat","Lyndem, Sona","Singha Roy, Atanu","32362245"],"abstract":["A new strain of a novel infectious disease affecting millions of people, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently been declared as a pandemic by the World Health Organization (WHO). Currently, several clinical trials are underway to identify specific drugs for the treatment of this novel virus. The inhibition of the SARS-CoV-2 main protease is necessary for the blockage of the viral replication. Here, in this study, we have utilized a blind molecular docking approach to identify the possible inhibitors of the SARS-CoV-2 main protease, by screening a total of 33 molecules which includes natural products, anti-virals, anti-fungals, anti-nematodes and anti-protozoals. All the studied molecules could bind to the active site of the SARS-CoV-2 protease (PDB: 6Y84), out of which rutin (a natural compound) has the highest inhibitor efficiency among the 33 molecules studied, followed by ritonavir (control drug), emetine (anti-protozoal), hesperidin (a natural compound), lopinavir (control drug) and indinavir (anti-viral drug). All the molecules, studied out here could bind near the crucial catalytic residues, HIS41 and CYS145 of the main protease, and the molecules were surrounded by other active site residues like MET49, GLY143, HIS163, HIS164, GLU166, PRO168, and GLN189. As this study is based on molecular docking, hence being particular about the results obtained, requires extensive wet-lab experimentation and clinical trials under in vitro as well as in vivo conditions."],"journal":"J Biomol Struct Dyn","authors":["Das, Sourav","Sarmah, Sharat","Lyndem, Sona","Singha Roy, Atanu"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362245","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1080/07391102.2020.1763201","keywords":["sars-cov-2 mpro","anti-fungals","anti-virals","molecular docking","natural products"],"e_drugs":["Hesperidin","Rutin","Lopinavir","Ritonavir","Emetine","Indinavir"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138496074514434,"score":306.9178}]}